Agency Launches Commissioner’s National Priority Voucher Program to Accelerate Drug Approvals Aligned with National Health Needs
June 17, 2025 | |
Agency Launches Commissioner’s National Priority Voucher Program to Accelerate Drug Approvals Aligned with National Health Needs
The Food and Drug Administration (FDA) announced the Commissioner’s National Priority Voucher (CNPV) program, a new initiative designed to expedite the drug approval process for companies that align with U.S. national health priorities (FAQ). Unlike traditional review timelines of 10–12 months, the CNPV allows eligible applications to be reviewed in just 1–2 months. These vouchers will be granted to drug… (Colocho, June 17, 2025) #Prescription Drugs
